Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wesselschmidt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|August 8, 1997
Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytesS Shresta, P Goda, R Wesselschmidt, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1993
Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparinR Wesselschmidt, K Likert, Z Huang, et al.
Blood|April 25, 1992
Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor XaR Wesselschmidt, K Likert, T Girard, et al.
Immunity|November 1, 1996
Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient miceF Liu, H Y Wu, R Wesselschmidt, et al.
Restorative Neurology and Neuroscience|February 16, 2002
A gene expression profile of embryonic stem cells and embryonic stem cell-derived neuronsJ F Loring, J G Porter, J Seilhammer, et al.
Advances in Experimental Medicine and Biology|January 11, 1992
The interaction between LACI and heparinG J Broze, R Wesselschmidt, D Higuchi, et al.
Nucleic Acids Research|June 5, 1998
Stochastic, stage-specific mechanisms account for the variegation of a human globin transgeneT A Graubert, B A Hug, R Wesselschmidt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|August 8, 1997
Residual cytotoxicity and granzyme K expression in granzyme A-deficient cytotoxic lymphocytesS Shresta, P Goda, R Wesselschmidt, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1993
Structural requirements for tissue factor pathway inhibitor interactions with factor Xa and heparinR Wesselschmidt, K Likert, Z Huang, et al.
Blood|April 25, 1992
Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of factor XaR Wesselschmidt, K Likert, T Girard, et al.
Immunity|November 1, 1996
Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient miceF Liu, H Y Wu, R Wesselschmidt, et al.
Restorative Neurology and Neuroscience|February 16, 2002
A gene expression profile of embryonic stem cells and embryonic stem cell-derived neuronsJ F Loring, J G Porter, J Seilhammer, et al.
Advances in Experimental Medicine and Biology|January 11, 1992
The interaction between LACI and heparinG J Broze, R Wesselschmidt, D Higuchi, et al.
Nucleic Acids Research|June 5, 1998
Stochastic, stage-specific mechanisms account for the variegation of a human globin transgeneT A Graubert, B A Hug, R Wesselschmidt, et al.
Pageof 1